Analysis of Survival Rate and Influencing Factors in Surgical Treatment of Primary Hepatocellular Carcinoma

Jianfei Wu, Guodong Yu, Xixi Tian, Quan Zhang
{"title":"Analysis of Survival Rate and Influencing Factors in Surgical Treatment of Primary Hepatocellular Carcinoma","authors":"Jianfei Wu, Guodong Yu, Xixi Tian, Quan Zhang","doi":"10.54097/6yjb4825","DOIUrl":null,"url":null,"abstract":"Objective: To study the survival rate of patients with primary hepatocellular carcinoma (HCC) undergoing clinical surgical treatment and various influencing factors, with the aim of further improving the survival rate of primary HCC patients. Methods: Sixty patients with primary hepatocellular carcinoma who underwent liver cancer resection surgery between January 2020 and December 2022 in our hospital were selected. A retrospective analysis was conducted on the patients' clinical characteristics (family medical history, alpha-fetoprotein levels, degree of liver cirrhosis, vascular invasion), treatment methods (surgical techniques, adjunctive therapies), and prognosis. The survival rate of patients and the influencing factors on the postoperative survival rate were analyzed. Results: There was a statistically significant difference in the five-year survival rate comparisons between different liver cirrhosis statuses, tumor sizes, preoperative alpha-fetoprotein levels, vascular invasion statuses, adjunctive treatment methods, and family medical histories (P < 0.05). Comparisons between different genders, ages, tumor locations, tumor pathological types, hepatitis B surface antigens, Child-Pugh classifications of liver function, tumor numbers, and methods of liver cancer resection showed no statistically significant differences (P > 0.05). Liver cirrhosis, tumor size ≥ 5cm, preoperative alpha-fetoprotein level > 400ng/ml, change in alpha-fetoprotein levels pre-and post-surgery, vascular invasion, adjunctive treatment methods, and PLC family medical history are independent factors influencing the survival rate of surgical treatment in primary HCC patients. Conclusion: There are several factors affecting the postoperative survival rate of primary HCC patients. Clinicians need to take a comprehensive approach. For high-risk patients, regular follow-ups are necessary, coupled with early diagnosis and treatment, to improve the prognosis. This approach is worth promoting. ","PeriodicalId":182292,"journal":{"name":"International Journal of Biology and Life Sciences","volume":"1 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Biology and Life Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54097/6yjb4825","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To study the survival rate of patients with primary hepatocellular carcinoma (HCC) undergoing clinical surgical treatment and various influencing factors, with the aim of further improving the survival rate of primary HCC patients. Methods: Sixty patients with primary hepatocellular carcinoma who underwent liver cancer resection surgery between January 2020 and December 2022 in our hospital were selected. A retrospective analysis was conducted on the patients' clinical characteristics (family medical history, alpha-fetoprotein levels, degree of liver cirrhosis, vascular invasion), treatment methods (surgical techniques, adjunctive therapies), and prognosis. The survival rate of patients and the influencing factors on the postoperative survival rate were analyzed. Results: There was a statistically significant difference in the five-year survival rate comparisons between different liver cirrhosis statuses, tumor sizes, preoperative alpha-fetoprotein levels, vascular invasion statuses, adjunctive treatment methods, and family medical histories (P < 0.05). Comparisons between different genders, ages, tumor locations, tumor pathological types, hepatitis B surface antigens, Child-Pugh classifications of liver function, tumor numbers, and methods of liver cancer resection showed no statistically significant differences (P > 0.05). Liver cirrhosis, tumor size ≥ 5cm, preoperative alpha-fetoprotein level > 400ng/ml, change in alpha-fetoprotein levels pre-and post-surgery, vascular invasion, adjunctive treatment methods, and PLC family medical history are independent factors influencing the survival rate of surgical treatment in primary HCC patients. Conclusion: There are several factors affecting the postoperative survival rate of primary HCC patients. Clinicians need to take a comprehensive approach. For high-risk patients, regular follow-ups are necessary, coupled with early diagnosis and treatment, to improve the prognosis. This approach is worth promoting. 
原发性肝细胞癌手术治疗的存活率及影响因素分析
研究目的研究接受临床手术治疗的原发性肝细胞癌(HCC)患者的生存率及各种影响因素,以期进一步提高原发性肝细胞癌患者的生存率。研究方法选取2020年1月至2022年12月期间在我院接受肝癌切除手术的60例原发性肝细胞癌患者。对患者的临床特征(家族病史、甲胎蛋白水平、肝硬化程度、血管侵犯)、治疗方法(手术技术、辅助治疗)和预后进行回顾性分析。分析了患者的存活率以及术后存活率的影响因素。结果不同肝硬化状态、肿瘤大小、术前甲胎蛋白水平、血管侵犯状态、辅助治疗方法和家族病史之间的五年生存率比较差异有统计学意义(P < 0.05)。不同性别、年龄、肿瘤位置、肿瘤病理类型、乙型肝炎表面抗原、Child-Pugh 肝功能分级、肿瘤数量和肝癌切除方法之间的比较结果显示,差异无统计学意义(P > 0.05)。肝硬化、肿瘤大小≥5cm、术前甲胎蛋白水平>400ng/ml、术前术后甲胎蛋白水平变化、血管侵犯、辅助治疗方法和 PLC 家族病史是影响原发性 HCC 患者手术治疗生存率的独立因素。结论影响原发性 HCC 患者术后生存率的因素有很多。临床医生需要采取综合措施。对于高危患者,有必要进行定期随访,再加上早期诊断和治疗,以改善预后。这种方法值得推广。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信